awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37174738-277CA8A7-CC62-4860-83C0-821B86FBAC8F
Q37174738-277CA8A7-CC62-4860-83C0-821B86FBAC8F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37174738-277CA8A7-CC62-4860-83C0-821B86FBAC8F
Randomised phase III trial of FEC120 vs EC-docetaxel in patients with high-risk node-positive primary breast cancer: final survival analysis of the ADEBAR study.
P2860
Q37174738-277CA8A7-CC62-4860-83C0-821B86FBAC8F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37174738-277CA8A7-CC62-4860-83C0-821B86FBAC8F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3826001b43da3765d97a1d4d3e51eff5eafb4e06
P2860
Intense dose-dense sequential chemotherapy with epirubicin, paclitaxel, and cyclophosphamide compared with conventionally scheduled chemotherapy in high-risk primary breast cancer: mature results of an AGO phase III study.